Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Cervical Cancer

Free Subscription 24.11.2025 1 ACS Appl Bio Mater 1 Adv Biol (Weinh) 1 Am J Clin Pathol 1 Ann Med 1 Arch Gynecol Obstet 1 Biomark Med 1 BMC Cancer 1 BMC Health Serv Res 1 BMC Med Genomics 2 BMC Med Imaging 1 BMC Public Health 1 BMC Womens Health 1 BMJ Glob Health 1 Br J Radiol 2 Brachytherapy 1 Cancer 5 Cancer Causes Control 1 Cancer Control 1 Cancer Lett 1 Cell Signal 1 Chromosoma 1 Clin Nucl Med 1 Cureus 1 Curr Opin Obstet Gynecol 1 Cytotechnology 2 Discov Oncol 1 Eur J Radiol 1 FP Essent 1 Front Immunol 2 Front Oncol 2 Front Public Health 1 Gan To Kagaku Ryoho 1 Gynecol Oncol 1 Hum Vaccin Immunother 1 Int J Gynaecol Obstet 4 Int J Gynecol Cancer 2 Int J Radiat Oncol Biol Phys 1 Int J Surg 1 Int J Womens Health 1 Iran J Allergy Asthma Immunol 1 J Adv Pharm Technol Res 1 J Adv Res 1 J Appl Clin Med Phys 1 J Cell Mol Med 1 J Clin Pathol 1 J Epidemiol Glob Health 3 J Gynecol Oncol 1 J Immunother Cancer 1 J Med Screen 3 J Pak Med Assoc 1 Lab Invest 1 Lancet 1 Lancet Glob Health 1 Life Sci 1 Med Decis Making 3 Medicine (Baltimore) 2 Mod Pathol 1 Nat Rev Clin Oncol 1 Nitric Oxide 1 Oncol Lett 1 Oncol Rep 2 Pak J Med Sci 1 Pathol Res Pract 1 Phytomedicine 1 PLOS Glob Public Health 1 PLoS Negl Trop Dis 2 PLoS One 1 Public Health Pract (Oxf) 5 Sci Rep 1 STAR Protoc 5 Transl Cancer Res 1 Value Health Reg Issues 1 Virol J 1 Virus Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

ACS Appl Bio Mater

1. AGRAWAL R, Shetake N, Verma G, Pandey BN, et al
   Nanoarchitectures of Folate-Functionalized Highly Monodispersed Ce-Tb Doped Core@Shell Nanorods for Targeted and Enhanced Chemotherapy of Human Cervical and Triple-Negative Breast Carcinoma.
   ACS Appl Bio Mater. 2025;8:10006-10023.
   PubMed         Abstract available
   
   

   
   Adv Biol (Weinh)

2. LIRA GA, de Azevedo FM, Lins IGS, Crispim JCO, et al
   FOXP3 Polymorphism and Upregulation of the CXCL12-CXCR4-SNAIL Axis with High Infiltration of M2TAM by STAT3/NFKB Pathways Influence the Survival of Cervical Cancer Patients.
   Adv Biol (Weinh). 2025 Nov 20:e00354. doi: 10.1002/adbi.202500354.
   PubMed         Abstract available
   
   

   
   Am J Clin Pathol

3. MURPHY KM, Weatherhead K, Chenault C, Nguyen C, et al
   Impact of the Genius Digital Diagnostics System on workflow and accuracy compared with the ThinPrep Imaging System for review of ThinPrep Papanicolaou tests.
   Am J Clin Pathol. 2025;164:746-751.
   PubMed         Abstract available
   
   

   
   Ann Med

4. CHANG L, Kang Y, Zhuo Y, Liu J, et al
   Comprehensive clinical analysis of gastric-type endocervical adenocarcinoma: a real-world multicenter study.
   Ann Med. 2025;57:2584735.
   PubMed         Abstract available
   
   

   
   Arch Gynecol Obstet

5. ENGLER T, Nagele M, Dannehl D, Englisch A, et al
   Management and natural course of CIN 1 and CIN 2 before and after implementation of the revised cervical cancer screening in Germany.
   Arch Gynecol Obstet. 2025 Nov 16. doi: 10.1007/s00404-025-08190.
   PubMed         Abstract available
   
   

   
   Biomark Med

6. MASOOD S, Sharad P, Kushwah AS, Masood O, et al
   MicroRNAs and HPV oncogenes crosstalk, their biomarker potential and therapeutic utility in cervical cancer.
   Biomark Med. 2025 Nov 17:1-13. doi: 10.1080/17520363.2025.2590779.
   PubMed         Abstract available
   
   

   
   BMC Cancer

7. BARDOE D
   Predictors of non-screening for cervical cancer in Ghana: an application of Andersen's behavioural model of health services use among pregnant women in Pru East municipality.
   BMC Cancer. 2025;25:1783.
   PubMed         Abstract available
   
   

   
   BMC Health Serv Res

8. LURGAIN JG, Peremiquel-Trillas P, Ouaarab-Essadek H, Mellouki K, et al
   Moroccan and Pakistani women's knowledge and perceptions on cervical cancer screening and HPV self-sampling acceptability in Catalonia, Spain: a mixed-methods study.
   BMC Health Serv Res. 2025;25:1502.
   PubMed         Abstract available
   
   

   
   BMC Med Genomics

9. HOU Z, Tang G, Chu H, Wang Z, et al
   Machine learning-based screening and validation of pyroptosis-associated prognostic genes and potential drugs in cervical cancer.
   BMC Med Genomics. 2025;18:183.
   PubMed         Abstract available
   
   

   
   BMC Med Imaging

10. YUAN ZL, Shi DW, Guan H, Liu F, et al
    MRI cytometry imaging for cervical cancer differential diagnosis: a preliminary study.
    BMC Med Imaging. 2025;25:474.
    PubMed         Abstract available
    
    
11. M D A, B V
    SegResDeiT: a hybrid SegNet-ResNet-50-DeiT framework for automated cervical cancer segmentation and classification.
    BMC Med Imaging. 2025;25:469.
    PubMed         Abstract available
    
    

    
    BMC Public Health

12. SINGH G, Dash NR, Shaju A, Chakkalakkunnan SS, et al
    Perceptions and sentiments associated with HPV vaccine uptake among Indian Reddit users: a qualitative social media analysis.
    BMC Public Health. 2025;25:4037.
    PubMed         Abstract available
    
    

    
    BMC Womens Health

13. XING W, Wang Z, Zhu Y, Ge G, et al
    Prognostic value of combining nutritional inflammatory index trajectories and tumor characteristics in cervical cancer.
    BMC Womens Health. 2025;25:567.
    PubMed         Abstract available
    
    

    
    BMJ Glob Health

14. WAPMUK AE, Obionu I, Obiezu-Umeh C, Gbaja-Biamila TA, et al
    Intersectional stigma and resilience in the uptake of cervical cancer prevention services in Nigeria: a qualitative study.
    BMJ Glob Health. 2025;10:e020065.
    PubMed         Abstract available
    
    

    
    Br J Radiol

15. ZHANG J, Jin LF, Jia C, Zhang HP, et al
    Assessing Local Invasion in Cervical Cancer: The Diagnostic Performance of Transrectal Contrast-Enhanced Ultrasonography.
    Br J Radiol. 2025 Nov 19:tqaf283. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Brachytherapy

16. LI H, Li X, Zhang J, Dai Y, et al
    AI-assisted 3D-printed transvaginal template guidance for interstitial brachytherapy in patients with cervical cancer with parametrial invasion.
    Brachytherapy. 2025 Nov 15:S1538-4721(25)00355.
    PubMed         Abstract available
    
    
17. JHAVAR S, Gomber G, Patel M, Klopp A, et al
    Exploring access to brachytherapy for cervical cancer in Texas: Geographic availability and distribution.
    Brachytherapy. 2025 Nov 14:S1538-4721(25)00307.
    PubMed         Abstract available
    
    

    
    Cancer

18. YE Z, Zhao Y, Wang J, Wang Q, et al
    Pooled performance of urinary human papillomavirus (HPV) testing for the presence of cervical HPV.
    Cancer. 2025;131:e70175.
    PubMed         Abstract available
    
    

    
    Cancer Causes Control

19. KIM SK, Duncan R, Chittams J, Teitelman AM, et al
    Evaluating Now I Know mHealth intervention promoting HPV vaccine completion among young women attending federally supported clinics.
    Cancer Causes Control. 2025;36:1989-2000.
    PubMed         Abstract available
    
    
20. JANIO E, Kahl AR, Kpozehouen D, Askelson N, et al
    Association of distance to diagnosis and area-based social measures with stage at diagnosis among Iowans with HPV-related cancers.
    Cancer Causes Control. 2025;36:1881-1890.
    PubMed         Abstract available
    
    
21. PALMER KNB, Mantina NM, Adegboyega A, Sokale IO, et al
    Group concept mapping to develop a salon-based HPV self-collection intervention.
    Cancer Causes Control. 2025;36:1753-1762.
    PubMed         Abstract available
    
    
22. GANGULY AP, DeWalt DA, Brenner AT, Reuland DS, et al
    Child caregiving and cancer screening: a nationally representative analysis.
    Cancer Causes Control. 2025;36:1731-1741.
    PubMed         Abstract available
    
    
23. TIITI TA, Aluko O, Barrett C
    Knowledge of human papillomavirus and self-sampling, including vaccination practices among female students in Free State, South Africa.
    Cancer Causes Control. 2025;36:1705-1717.
    PubMed         Abstract available
    
    

    
    Cancer Control

24. BESO DELGADO M, Ibanez Cabanell J, Castan Cameo S, Mira Solves JJ, et al
    Optimisation of a Cervical Cancer Screening Model Based on Self-Sampling for Human Papillomavirus Testing.
    Cancer Control. 2025;32:10732748251378812.
    PubMed         Abstract available
    
    

    
    Cancer Lett

25. NI Y, Zhou X, Tang Y, Ren W, et al
    SB225002 Enhances Radiosensitivity in Cervical Cancer via Direct Neutrophil Inhibition and Tumor Cell Suppression.
    Cancer Lett. 2025 Nov 17:218153. doi: 10.1016/j.canlet.2025.218153.
    PubMed         Abstract available
    
    

    
    Cell Signal

26. LI J, Li J, Chen X
    Oncogenic role of PLOD3 mediated by SOX9 through IL-6/JAK/STAT3 pathway in cervical cancer.
    Cell Signal. 2025;138:112250.
    PubMed         Abstract available
    
    

    
    Chromosoma

27. RANGA S, Yadav R, Chauhan MB, Chauhan P, et al
    Molecular and bioinformatics analysis of long non-coding RNAs in cervical cancer.
    Chromosoma. 2025;134:11.
    PubMed         Abstract available
    
    

    
    Clin Nucl Med

28. WANG G, Liu X, Si Z, Wang Z, et al
    A Scallop-shaped Photopenic Region in the Urinary Bladder Area on Tc-99m MDP Bone Scan Caused by a Uterine Cervical Leiomyoma.
    Clin Nucl Med. 2025;50:1243-1244.
    PubMed         Abstract available
    
    

    
    Cureus

29. MEDA S, Musunuri B, Shetty S, Udupa K, et al
    A Rare Metastasis to the Stomach From Cervical Cancer: A Case Report and Review of the Literature.
    Cureus. 2025;17:e94889.
    PubMed         Abstract available
    
    

    
    Curr Opin Obstet Gynecol

30. MUZZARELLI A, Paderno M, Lorusso D
    New developments in the treatment of cervical cancer in 2026.
    Curr Opin Obstet Gynecol. 2025 Nov 18. doi: 10.1097/GCO.0000000000001079.
    PubMed         Abstract available
    
    

    
    Cytotechnology

31. HE Y, Hou J, Deng Y, Huang R, et al
    CircUSP36 promotes FBXO5 expression to accelerate cervical cancer progression by targeting miR-520d-5p.
    Cytotechnology. 2025;77:197.
    PubMed         Abstract available
    
    

    
    Discov Oncol

32. KUMARI K, Gupta RK, Kumar S, Prasad SB, et al
    Genes associated with epithelial mesenchymal transition (EMT) in cervical cancer progression.
    Discov Oncol. 2025 Nov 20. doi: 10.1007/s12672-025-04011.
    PubMed         Abstract available
    
    
33. SUN W, Liu Q, Hao Y, Liu Y, et al
    Development and validation of a deep learning model for individualized survival prediction in advanced cervical cancer.
    Discov Oncol. 2025 Nov 18. doi: 10.1007/s12672-025-03920.
    PubMed         Abstract available
    
    

    
    Eur J Radiol

34. WANG S, Liu X, Wang Z, Pan Y, et al
    Mr-based radiomics analysis of intra-tumor heterogeneity for early treatment response prediction in locally advanced cervical cancer treated with concurrent chemoradiotherapy.
    Eur J Radiol. 2025;194:112547.
    PubMed         Abstract available
    
    

    
    FP Essent

35. PARUCHURI B, Miller A
    Gynecologic Cancers: Cervical Cancer.
    FP Essent. 2025;558:6-14.
    PubMed         Abstract available
    
    

    
    Front Immunol

36. KLIMOV-KRAVTCHENKO K, Baltazar-Diaz TA, Haramati J, Castano-Jimenez PA, et al
    Microbiota-immune dysregulation in cervical cancer patients from Western Mexico: linking gut dysbiosis and NK cell exhaustion as promising biomarkers.
    Front Immunol. 2025;16:1637098.
    PubMed         Abstract available
    
    

    
    Front Oncol

37. SUN Y, Zhou F, Zhong X, Lv X, et al
    Hippo signaling pathway in cervical cancer: insights into mechanisms and therapeutic potential.
    Front Oncol. 2025;15:1662499.
    PubMed         Abstract available
    
    
38. WANG Y, Gan N, Ning S, Qiu Y, et al
    Prognostic value and early response stratification of a multi-biomarker panel in cervical cancer patients undergoing chemoradiotherapy.
    Front Oncol. 2025;15:1686716.
    PubMed         Abstract available
    
    

    
    Front Public Health

39. WANG R, Liu B, Wei SW, Liu YR, et al
    Meta-analysis of factors influencing depression in cervical cancer patients.
    Front Public Health. 2025;13:1657690.
    PubMed         Abstract available
    
    
40. D'AMBROSIO F, Sezzatini R, Bucciardini R, Maida A, et al
    Educational interventions and communication strategies to improve HPV immunization uptake: a systematic literature review.
    Front Public Health. 2025;13:1675946.
    PubMed         Abstract available
    
    

    
    Gan To Kagaku Ryoho

41. TOHYA T, Ozono K
    [Occurrence of Malignant Peritoneal Mesothelioma 19 Years after Concurrent Chemoradiation Therapy for Uterine Cervical Cancer Stage ?B-A Case Report and Literature Review].
    Gan To Kagaku Ryoho. 2025;52:823-824.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol

42. BAO W, He X, Huang Y, Xing A, et al
    Effect of uterine manipulator on stage IB1 to IIA1 cervical cancer: A retrospective cohort study.
    Gynecol Oncol. 2025;204:27-36.
    PubMed         Abstract available
    
    

    
    Hum Vaccin Immunother

43. ALGHAMDI R, Alghamdi M, Farsi N, Alyafi M, et al
    Knowledge of the human papilloma virus and acceptance of its vaccine among male and female young adults in Jeddah, Saudi Arabia: A cross-sectional study.
    Hum Vaccin Immunother. 2025;21:2583609.
    PubMed         Abstract available
    
    

    
    Int J Gynaecol Obstet

44. HINOJOSA-GONZALEZ DE, Escarcega-Bordagaray JA, Murillo-Torres RM, Torres-Martinez M, et al
    Immune checkpoint therapy in locally advanced, persistent, recurrent, and metastatic cervical cancer: A systematic review and Bayesian network meta-analysis.
    Int J Gynaecol Obstet. 2025 Nov 15. doi: 10.1002/ijgo.70648.
    PubMed         Abstract available
    
    

    
    Int J Gynecol Cancer

45. PERALTA J, Caicedo L, Rodriguez J, Viveros-Carreno D, et al
    Oncological impact of pelvic vessels embolization in patients with locally advanced cervical cancer treated with concomitant chemoradiotherapy.
    Int J Gynecol Cancer. 2025;36:102776.
    PubMed         Abstract available
    
    
46. MAMEDE I, Riya IJ, Piya IJ, Nohmi RL, et al
    Adjuvant, neoadjuvant, and surgical treatment for locally advanced cervical cancer: a Bayesian network meta-analysis.
    Int J Gynecol Cancer. 2025;36:102750.
    PubMed         Abstract available
    
    
47. PENG Y, Chen M, Liang T, Wang Y, et al
    Distribution and maturity of tertiary lymphoid structures predict recurrence-free survival in cervical cancer.
    Int J Gynecol Cancer. 2025;36:102718.
    PubMed         Abstract available
    
    
48. SON Y, Hong S, Jang W, Kim S, et al
    Global, regional, and national burden of cervical cancer in 2022 and projections to 2050: a population-based analysis of GLOBOCAN.
    Int J Gynecol Cancer. 2025;36:102751.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

49. HU HP, Leung E
    Target Modification and Brachytherapy: Considerations When Radiating Cervical Cancer With a Pelvic Kidney.
    Int J Radiat Oncol Biol Phys. 2025;123:1215.
    PubMed        
    
    
50. YOUNG S, D'Souza DP
    Treating Cervical Cancer in a Patient With Pelvic Kidney: Navigating a Narrow Therapeutic Window.
    Int J Radiat Oncol Biol Phys. 2025;123:1213-1214.
    PubMed        
    
    

    
    Int J Surg

51. SU L, Zhang J, Yao J, Ren Y, et al
    ADCs in cervical cancer: current clinical trial landscape and future prospects.
    Int J Surg. 2025 Nov 17. doi: 10.1097/JS9.0000000000003732.
    PubMed        
    
    

    
    Int J Womens Health

52. ZHOU W, Wang Y, Long H, Wang J, et al
    Construction of a Nomogram Prediction Model for Individualized Prediction of Cervical Cancer Risk: A Retrospective Study.
    Int J Womens Health. 2025;17:4435-4446.
    PubMed         Abstract available
    
    

    
    Iran J Allergy Asthma Immunol

53. XIANG M, Yu Y, Gao Q, Xing J, et al
    MiR-425-5p Mediation of Malignant Behavior and Immune Escape of Cervical Cancer Cells by Targeting NCAM1.
    Iran J Allergy Asthma Immunol. 2025;24:834-850.
    PubMed         Abstract available
    
    

    
    J Adv Pharm Technol Res

54. BENJAWAN L, Sathalalai P, Promdaeng S, Sukkhung S, et al
    Supercritical CO(2) extraction of Clinacanthus nutans: Enhanced bioactive recovery and cytotoxicity against cervical cancer cells.
    J Adv Pharm Technol Res. 2025;16:235-241.
    PubMed         Abstract available
    
    

    
    J Adv Res

55. LI X, Qin X, Zhao X, Liu Y, et al
    Spatial multi-omics guides ASCT2-targeted delivery of glycolysis inhibitor for cervical cancer suppression and chemoresistance reversal.
    J Adv Res. 2025 Nov 16:S2090-1232(25)00931-2. doi: 10.1016/j.jare.2025.
    PubMed         Abstract available
    
    

    
    J Appl Clin Med Phys

56. LEBRET D, Lafond C, Leseur J, Barateau A, et al
    Prospective multi-institutional study of library-based adaptive radiotherapy for cervical cancer: Evaluation of plan-of-the-day selection and population analysis.
    J Appl Clin Med Phys. 2025;26:e70356.
    PubMed         Abstract available
    
    

    
    J Cell Mol Med

57. NEISI N, Mousavikish F, Bastani MN, Parsanahad M, et al
    Impact of High-Risk HPV Infection on PI3K, MALAT1, H19 and LINC00460 Expression in Cervical Cells.
    J Cell Mol Med. 2025;29:e70949.
    PubMed         Abstract available
    
    

    
    J Clin Pathol

58. YAN P, Dong Y, Zhang F, Zhen T, et al
    Claudin18.2 expression and its clinicopathological feature in adenocarcinoma from various parts.
    J Clin Pathol. 2025;78:815-821.
    PubMed         Abstract available
    
    

    
    J Epidemiol Glob Health

59. REDROBAN JDS, Lopez D, Santillan C
    A Narrative Review of Human Papillomavirus (HPV) Vaccination in Ecuador: A Crisis of Inequity and an Evidence-Based Roadmap for Elimination.
    J Epidemiol Glob Health. 2025;15:135.
    PubMed         Abstract available
    
    

    
    J Gynecol Oncol

60. PIYA IJ, Riya IJ, Sharma V
    Efficacy and safety of immune checkpoint inhibitors with chemoradiotherapy/chemotherapy in locally advanced cervical cancer patients: a systematic review and single-arm meta-analysis.
    J Gynecol Oncol. 2025 Oct 24. doi: 10.3802/jgo.2026.
    PubMed         Abstract available
    
    
61. TAY SK, Wastlund D, Sim RSY, Karichu J, et al
    Cost-effectiveness analysis of reflex p16/Ki-67 dual-stained cytology in HPV partial genotyping screening in Singapore.
    J Gynecol Oncol. 2025;36:e115.
    PubMed         Abstract available
    
    
62. BAEK JY, Kim HS, Cho WK, Kim BG, et al
    Significance of HPV status on tumor response and treatment outcomes in endocervical adenocarcinoma treated with definitive chemoradiotherapy: a retrospective study.
    J Gynecol Oncol. 2025;36:e92.
    PubMed         Abstract available
    
    

    
    J Immunother Cancer

63. CAO G, Wang Y, Zeng H, Zhi Y, et al
    Oligoclonal tumor-specific CD8 T-cell revival and IRE1alpha/XBP1-GDF15-mediated immunosuppressive niches determine neoadjuvant chemoimmunotherapy efficacy in cervical cancer.
    J Immunother Cancer. 2025;13:e012630.
    PubMed         Abstract available
    
    

    
    J Med Screen

64. ADEFEMI K, Knight JC, Zhu Y, Wang PP, et al
    Concurrent cancer screening participation and associated factors among Canadian women: Insights from a cross-sectional study.
    J Med Screen. 2025;32:205-214.
    PubMed         Abstract available
    
    

    
    J Pak Med Assoc

65. WANG M, Zou X, Wang Z
    Meta-analysis about correlation between the human Papillomavirus infection and the incidence of cervical intraepithelial Neoplasia.
    J Pak Med Assoc. 2025;75.
    PubMed         Abstract available
    
    
66. ATIF M
    Human Papillomavirus (HPV) and Cervical Cancer: A Call to action for Pakistan.
    J Pak Med Assoc. 2025;75:1686-1687.
    PubMed        
    
    
67. AHSAN S
    Single dose HPV (Human Papilloma Virus) Vaccination for Cervical Cancer Prevention in Pakistan.
    J Pak Med Assoc. 2025;75:1519-1521.
    PubMed        
    
    

    
    Lab Invest

68. KIRSCHE L, Jansen L, Petzold A, Reinecke P, et al
    Heterogeneous Distribution of Human Papillomavirus (HPV) Integration Sites in Cervical Precancers Compromises the Diagnostic Accuracy of Integrant-Specific PCR.
    Lab Invest. 2025;105:104232.
    PubMed         Abstract available
    
    

    
    Lancet

69. ALLEMANI C, Minicozzi P, Morawski B, Lima CA, et al
    Global variation in patterns of care and time to initial treatment for breast, cervical, and ovarian cancer from 2015 to 2018 (VENUSCANCER): a secondary analysis of individual records for 275 792 women from 103 population-based cancer registries in 39
    Lancet. 2025 Oct 22:S0140-6736(25)01383-2. doi: 10.1016/S0140-6736(25)01383.
    PubMed         Abstract available
    
    

    
    Lancet Glob Health

70. BENARD E, Drolet M, Gingras G, Laprise JF, et al
    Ranking the most efficient human papillomavirus vaccination strategies in low-income and lower-middle income countries: a mathematical modelling analysis.
    Lancet Glob Health. 2025;13:e2153-e2164.
    PubMed         Abstract available
    
    

    
    Life Sci

71. WANG D, Duan Z, Chen M, Li W, et al
    Oncogenic GINS1 facilitates cervical cancer progression via FYN-mediated EMT regulation.
    Life Sci. 2025 Nov 14:124090. doi: 10.1016/j.lfs.2025.124090.
    PubMed         Abstract available
    
    

    
    Med Decis Making

72. SHI Y, Sun N, Ren J, Sun J, et al
    Vaccination Strategies against HPV Infection and Cervical Cancer in China: A Transmission Modeling Study.
    Med Decis Making. 2025 Nov 14:272989X251388915. doi: 10.1177/0272989X251388915.
    PubMed         Abstract available
    
    

    
    Medicine (Baltimore)

73. NIU H, Zheng J, Xie N, Jiang C, et al
    Discriminant study of cervical squamous cells based on computer image analysis.
    Medicine (Baltimore). 2025;104:e45630.
    PubMed         Abstract available
    
    
74. LYU W, Hu S, Li J
    Brachytherapy facilitates closure of malignant vesicovaginal fistulas: A case report and literature review.
    Medicine (Baltimore). 2025;104:e44708.
    PubMed         Abstract available
    
    
75. WANG S, Zhu P
    Expression and clinicopathological significance of KAI1, MACC1, and AGR2 in cervical squamous cell carcinoma.
    Medicine (Baltimore). 2025;104:e45992.
    PubMed         Abstract available
    
    

    
    Mod Pathol

76. YE Z, Zhang P, Wei R, Niu H, et al
    Deep Learning-Assisted System Improves Practical Effects in Cervical Cytopathology Diagnosis: A Comparative Study of Reading Modes.
    Mod Pathol. 2025;38:100882.
    PubMed         Abstract available
    
    
77. ASWOLINSKIY W, van der Post RS, Campora M, Baronchelli C, et al
    Attention-Based Whole-Slide Image Compression Achieves Pathologist-Level Prescreening of Multiorgan Routine Histopathology Biopsies.
    Mod Pathol. 2025;38:100827.
    PubMed         Abstract available
    
    

    
    Nat Rev Clin Oncol

78. ROMERO D
    Sentinel lymph node biopsy improves surgical management of cervical cancer.
    Nat Rev Clin Oncol. 2025 Nov 17. doi: 10.1038/s41571-025-01107.
    PubMed        
    
    

    
    Nitric Oxide

79. BDAY J, Souid M, Farhat KH, Macherki Y, et al
    Involvement of endothelial nitric oxide synthase (eNOS) and nitric oxide (NO) levels in precancerous and cancerous cervical lesions.
    Nitric Oxide. 2025;159:176-185.
    PubMed         Abstract available
    
    

    
    Oncol Lett

80. ZHOU X, An R, Li X
    Cervical cancer immune microenvironment: Mechanisms of HPV-mediated immune evasion and advances in immunotherapy (Review).
    Oncol Lett. 2025;31:22.
    PubMed         Abstract available
    
    

    
    Oncol Rep

81. LIU S, Pan X, Yang Q, Wen L, et al
    [Retracted] MicroRNA?18a enhances the radiosensitivity of cervical cancer cells by promoting radiation?induced apoptosis.
    Oncol Rep. 2026;55:18.
    PubMed         Abstract available
    
    

    
    Pak J Med Sci

82. SHAMSI U, Saleem S, Usman N, Azam I, et al
    Late-stage diagnosis and its impact on survival in Pakistani women with cervical cancer: Findings from an institutional cancer registry.
    Pak J Med Sci. 2025;41:2709-2714.
    PubMed         Abstract available
    
    
83. WANG X, Wang F, Yang W, Li Y, et al
    Exploring the significance of GNG11, LPAR1, and AGTR1 in early diagnosis and prognosis of cervical cancer: A correlative analysis with clinical characteristics.
    Pak J Med Sci. 2025;41:2776-2783.
    PubMed         Abstract available
    
    

    
    Pathol Res Pract

84. PEDREANEZ A, Carrero Y, Vargas R, Fonseca JPH, et al
    Role of C-reactive protein in cervical intraepithelial neoplasia/cancer.
    Pathol Res Pract. 2025;276:156274.
    PubMed         Abstract available
    
    

    
    Phytomedicine

85. CHEN G, Wang M, Lin E, Zheng N, et al
    Herbal medicines for radiation vaginitis: A systematic review and meta-analysis.
    Phytomedicine. 2025;148:157367.
    PubMed         Abstract available
    
    

    
    PLOS Glob Public Health

86. PAZ-SOLDAN VA, Nussbaum L, Brown J, Meza-Sanchez G, et al
    A realist evaluation of a novel cervical cancer prevention strategy in Iquitos, Peru.
    PLOS Glob Public Health. 2025;5:e0004517.
    PubMed         Abstract available
    
    

    
    PLoS Negl Trop Dis

87. MERTELSMANN AM, Maganga JK, Lee MH, Ward M, et al
    Schistosoma haematobium infection is associated with oncogenic gene expression in Cervical Mucosa, with enhanced effects following treatment: A pilot study.
    PLoS Negl Trop Dis. 2025;19:e0013569.
    PubMed         Abstract available
    
    

    
    PLoS One

88. DONKOH ET, Abdul IW, Ahiakpa AK, Williams I, et al
    Protocol for a systematic review and meta-analysis of the impact of cervical cancer prevention initiatives in Ghana.
    PLoS One. 2025;20:e0337011.
    PubMed         Abstract available
    
    
89. HALVORSON-FRIED SM, Higgins ICA, Gilkey MB, Lazard AJ, et al
    Perceived effectiveness of messages to address cervical cancer screening barriers: An online experiment.
    PLoS One. 2025;20:e0336693.
    PubMed         Abstract available
    
    

    
    Public Health Pract (Oxf)

90. KHUNTSARIA I, Gachechiladze K, Liparta E, Kobulashvili T, et al
    Strategic implementation of HPV vaccination to eliminate cervical cancer in Georgia.
    Public Health Pract (Oxf). 2025;10:100679.
    PubMed         Abstract available
    
    

    
    Sci Rep

91. ZHANG Z, Li B, Li W, Wang Z, et al
    The relationship between CTCs, TFD and postoperative prognosis of cervical cancer patients and the construction of prediction models.
    Sci Rep. 2025;15:41307.
    PubMed         Abstract available
    
    
92. BEGUM D, Bassetty KC, Barmon D, Baruah U, et al
    Determinants of delay in presentation to completion of treatment in cervical cancer.
    Sci Rep. 2025;15:41329.
    PubMed         Abstract available
    
    
93. GUY MM, Mao Z, Yu Y, Liu Y, et al
    Development and validation of the risk stratification based on deep learning and radiomics to predict survival of advanced cervical cancer.
    Sci Rep. 2025;15:41202.
    PubMed         Abstract available
    
    
94. NEVILLE C, Reese S, Hughes B, Glennon K, et al
    Age, lifestyle, and disease affect ciliary transport in the human fallopian tube.
    Sci Rep. 2025;15:40594.
    PubMed         Abstract available
    
    
95. KARTHIKEYAN P, Malaserene I, Deepakraj E
    Explainable AI based cervical cancer prediction using FSAE feature engineering and H2O AutoML.
    Sci Rep. 2025;15:40439.
    PubMed         Abstract available
    
    

    
    STAR Protoc

96. SHETTY S, Prasada Kabekkodu S
    Protocol for investigating mitochondrial structure, function, and metabolism in human cervical cancer cells.
    STAR Protoc. 2025;6:104202.
    PubMed         Abstract available
    
    

    
    Transl Cancer Res

97. GUO R, Chai O, Li C, Xu Y, et al
    B7 homolog 6 promotes the killing activity of natural killer cells against cervical cancer through the downstream ERK pathway of NKp30.
    Transl Cancer Res. 2025;14:6536-6550.
    PubMed         Abstract available
    
    
98. XIE Z, Shen T, Wang Y, Ma R, et al
    RNA sequencing and bioinformatics analysis have identified MAST1 as a potential biomarker and therapeutic target for cervical cancer.
    Transl Cancer Res. 2025;14:7157-7169.
    PubMed         Abstract available
    
    
99. CHEN X, Hong C, Zhang G, Lin B, et al
    Cervical cancer molecular subtype identification and prognosis classification by a metabolism-related gene expression.
    Transl Cancer Res. 2025;14:6207-6221.
    PubMed         Abstract available
    
    
100. XU B, Shi X, Liu Y, Xu L, et al
     CC/CXC chemokine risk signature at single-cell resolution: a machine learning model for precision stratification in cervical cancer.
     Transl Cancer Res. 2025;14:6834-6848.
     PubMed         Abstract available
     
     
101. WU Z, Zhang J, Sun B, Wu Y, et al
     Construction and verification of a prognostic model for cervical cancer based on genes associated with the p53 regulatory pathway.
     Transl Cancer Res. 2025;14:6738-6757.
     PubMed         Abstract available
     
     

     
     Value Health Reg Issues

102. DO CARMO TM, Borba MACSM, de Mendonca Batista P, Rego MADC, et al
     Real-World Data on Cervical Cancer: The Impact of 2020 COVID-19 Outbreak on the Treatment Patterns and Healthcare Resources Utilization in Brazilian Public Health System.
     Value Health Reg Issues. 2025;52:101508.
     PubMed         Abstract available
     
     

     
     Virol J

103. ZHU L, Li P, Wang Y, Zhang S, et al
     The relationship between human papillomavirus genotype distribution and age and the association with high-grade squamous intraepithelial lesions of the cervix or cervical cancer in Jilin Province, China.
     Virol J. 2025;22:380.
     PubMed         Abstract available
     
     

     
     Virus Res

104. HASHIDA Y, Matsumoto S, Maeda N, Teshima M, et al
     Detection of partial deletions of the human papillomavirus 16 E6 gene in a subset of oropharyngeal and cervical cancers.
     Virus Res. 2025;361:199648.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.